The Royal Pharmaceutical Society (RPS) has launched a new position paper on 'How pharmacy can do more to tackle health inequalities'.
The RPS paper aims to help pharmacists and pharmacy teams to take action against health inequalities. It is designed to provide a reference source for pharmacy
teams to use over time to continually improve services.
RPS said: "Like all health services, these pharmacy services do not always reach everyone. Often it is people who are suffering the greatest inequalities that find
it most difficult to access the services that are currently available. This can be for a large number of reasons including poverty, education, being part of a group
vulnerable to exclusion, language and power."
Therefore, the RPS paper focuses not on "what" services pharmacy provides but "how" they are provided, with an aim of making them more accessible for people who are
currently struggling.
Claire Anderson, President of Royal Pharmaceutical Society said: "It's fantastic that pharmacy teams in every sector of pharmacy across Great Britain are providing
care that can improve health inequalities, with many patients able to access pharmacy services very easily. Brilliant examples of this shine through in the paper.
The Royal Pharmaceutical Society (RPS) and National Pharmacy Association (NPA) have both urged the new health secretary Steve Barclay to back the 'pharmacy first'
approach in England as mentioned by his predecessor on numerous occasions.
"Sajid Javid recognised the vital role of community pharmacy and the potential of a 'Pharmacy First' to support patient access to care. I would urge the new Health
Secretary to see this through to completion," said chair of RPS in England Thorrun Govind.
Thorrun hopes the new health secretary will engage with pharmacy leaders about how we can make the most of our health and care workforce to support the NHS recovery,
including reducing health inequalities, managing the growing cost of long-term conditions, and utilising the enhanced skills of Pharmacist Independent Prescribers.
Commenting on the new appointment, she said: "This is a crucial time for the future of health and care - with continued pressures on teams, changes to NHS structures
and organisations, and the need for long-term investment in the workforce.
"With a 'refresh' of the NHS Long-Term Plan and the Government's workforce plan expected later this year, these must support a more ambitious approach to advancing
the clinical role of pharmacists across the NHS to better meet changing patient demand, backed by investment in pharmacy education and training.
The 1000th Building the Community-Pharmacy Partnership (BCPP) programme in Centred Soul, Newry received funding from the Department of Health in Northern
Ireland to improve the health and wellbeing of women in the local community.
BCPP programme is led by Community Development and Health Network (CDHN) in Northern Ireland and is funded by the Department of Health.
It supports communities and community pharmacists to address locally defined needs so that people make connections, listen to and understand each other better and
work together to address the social determinants of health and health inequalities
Department of Health's Chief Pharmaceutical Officer, Cathy Harrison said: "I am delighted to mark the 1000th project to receive funding to improve health inequalities
in the Newry area.
"Since 2001 we have invested over £7 million in local community groups and pharmacy partnerships across Northern Ireland, to work together on a specific, local health
need.
"The Centred Soul project is a great example of how BCPP Programme contributes to tackling inequality and improving community health and wellbeing locally.
Pharmacy leaders have called for reassurance that the workforce plan, expected by April 2023, will cover the entirety of the pharmacy workforce across the
health service, including in community pharmacies.
A joint letter has been signed by representatives from 14 pharmacy organisations which highlights that with continued pressures on services, it is more important
than ever to support the pharmacy workforce so that the staff needed to deliver patient care now and into the future can be recruited, trained and retained.
Mark Koziol, Pharmacists' Defence Association (PDA) Chairman said: "Our pharmacist members practise across the entire health system and have the potential to do far
more to help patients and improve public health, but they can only do so safely if they are in appropriately staffed workplaces. This is a workforce issue, so it is
important that the Government works with representatives of the pharmacist workforce, and of their employers, to get a suitably agreed plan in place."
Thorrun Govind, English Pharmacy Board Chair, Royal Pharmaceutical Society (RPS), said: "It will be crucial to use the skills of all our health professions to support
the NHS recovery, reduce health inequalities, manage the growing cost of long-term conditions, and deliver best value from medicines.
NHS England and NHS Improvement (NHSE&I), in association with the Royal Pharmaceutical Society (RPS) and the Association of Pharmacy Technicians UK (APTUK),
has published its first inclusive pharmacy practice (IPP) bulletin, with an overarching ambition "to make community pharmacy a more inclusive environment for all
pharmacy professionals".
The IPP programme will take practical steps to improve the awareness and understanding at all levels of different cultural beliefs and attitudes, according to the
Pharmaceutical Services Negotiating Committee (PSNC).
As a member of the IPP Improving Practice and Engagement Group, PSNC has contributed to this issue of the Bulletin, which focuses on how pharmacy professionals can
help to reduce health inequalities via the detection and prevention of cardiovascular diseases.
The IPP programme, of which the Bulletin forms a part, aims to engage with local communities to help improve their health and reduce inequalities in care -
particularly among those from ethnically diverse and disadvantaged backgrounds.
The National Pharmacy Association (NPA) has called the future prime minister to deliver on the commitments made by the previous health secretaries to reform
primary care through a 'pharmacy first' approach and fairly fund community pharmacies to avoid closures.
In an open letter, the NPA has urged Rishi Sunak and Liz Truss, the two leadership contenders of the Conservative Party and prime ministerial candidates, to think
radically about the role of England's 11,000 pharmacies, which are on the frontline of healthcare across the country.
NPA also highlighted how pharmacies could help clear the NHS backlog, free up millions more GP appointments, dramatically improve access to primary health care and
do more to prevent ill health and support people with long term medical conditions.
"Because of our unparalleled presence in deprived areas, we also have great potential to level up access to healthcare and address health inequalities. We set these
ideas out in How We Can Help, which is an improvement plan already welcomed by many of your colleagues."
The General Pharmaceutical Council (GPhC) has published new reports on racism and other inequalities in pharmacy, following a series of virtual equality
roundtables.
This council organised its second equality roundtable on 18 September 2023, focussing on the topic of 'Language Barriers and Health Inequalities', and a follow-up
roundtable on 'Racism in Pharmacy: Accountability Counts' on 10 October 2023.
A wide range of pharmacy-related organisations, patient groups, equality groups, providers of translation services and software, individual pharmacists, pharmacy
technicians and wider teams from different sectors and settings attended the events.
GPhC chair, Gisela Abbam thanked speakers and attendees for listening and contributing to the important discussions around racism and language barriers, which she
said are "not purely a pharmacy problem, nor a health problem", but a "much broader" system problem.
"It is important we acknowledge that, and do what we can to tackle racism and barriers wherever we find them," she added.
A new report commissioned by the National Pharmacy Association (NPA) has revealed harsh financial realities faced by community pharmacies in England.
The report by Professor David Taylor of University College London warned that 1000s of community pharmacy closure might take place by 2024 in England if the sector
was not supported with additional funds.
At the launch of the report titled 'Protecting UK Public Interests in NHS Community Pharmacy', Prof Taylor said: "There will be several 1,000s of closures over the
next few years unless we take appropriate action, which doesn't mean to pour money all over it, but it is to fund appropriately when necessary.
"At the moment, if we got a partial collapse in the pharmacy network it would disrupt medicine supply and increase health inequalities… For me, it's missing out on
the future development of better and more accessible care, which would be the tragedy of reducing, harming and damaging the pharmacy network unnecessarily."
The National Pharmacy Association (NPA) highlighted the role played by community pharmacies during pandemic to provide urgent care and vital support to people
with long-term medical conditions at its opening remark in the Covid-19 public inquiry held on Tuesday (28 February).
NPA is the core participant in the Covid-19 public inquiry. lawyer Brian Stanton made an opening statement on the NPA's behalf which focused on three areas- health
inequalities and the needs of vulnerable patients; the impact of medicine shortages and medicine price increases and the challenge that community pharmacy faced in
responding to the pandemic and maintaining patient services following long-term under investment.
Stanton said: "The UK's community pharmacies were on the frontline of efforts to limit the impact of coronavirus and to keep people well, and as well as handling a
massive increase in demand for healthcare advice and medicines, they also continued to provide urgent care and vital support to people with long-term medical
conditions.
"However, there are now very many at risk of closure during to underfunding and when the Inquiry comes to consider its recommendations the NPA would encourage
you [the presiding judge] to think about how resilience can be built into future plans."
The statement included a compelling account of the commitment typical of so many pharmacies during the pandemic - from husband and wife Pete and Sukhi Johal, both
NPA members and pharmacists, who co-own Calow Pharmacy in Chesterfield.
"Only around half of ICSs have a Chief Pharmacist," indicating a significant gap in leadership that hampers the pharmacy sector's ability to influence
critical healthcare decision, a report on medicine optimisation by the Public Policy Projects (PPP) highlights.
In PPP's latest report, a notable concern highlighted is the inadequate representation of pharmacy leadership within Integrated Care Systems (ICSs) despite the
role of pharmacy being "central in the delivery of system priorities, with pivotal roles in improving population health and tackling inequalities".
In recent years, the role of pharmacy within the NHS has evolved significantly with recent developments including Pharmacy First Services and legislative
amendments that allows pharmacy technicians under PGDs to administer and supply medicines.
A leading pharmacist and member of the Royal Pharmaceutical Society (RPS) Scottish Pharmacy Board has been chosen to share her experiences of working in a community pharmacy in Scotland.
Catriona Sinclair FRPharmS will speak at a roundtable entitled 'International Experiences in Professional Pharmaceutical Health Services' in Madrid on Thursday
(May 5).
Catriona, who owns and runs a pharmacy in the Highlands, is expected to give her take on community pharmacies' significant contribution towards achieving improved
health outcomes and reducing health inequalities for local populations in Scotland.
As an active independent prescriber, she is at the cutting edge of the profession in Scotland.
Speaking ahead of her visit to Madrid, Catriona said: "I'm honoured to have the opportunity to collaborate with pharmacists from across Europe, and to share my
experiences of working as a community pharmacist in Scotland.
In a significant event organised by Eastern Eye (EE), a sister publication of Pharmacy Business, political leaders gathered on July 1st to address pressing
issues affecting the Asian community
The EE election debate aimed to amplify their political voice and encourage participation in the political process.
The debate, moderated by Barnie Choudhury, Editor of Eastern Eye, saw prominent figures including Andrew Boff AM of the Conservative Party, Anneliese Dodds
represented Labour as Shadow Secretary of State for Women and Equalities, and Lord Richard Newby from the Liberal Democrats engaged in a robust discussion.
They fielded questions on various issues affecting the UK, including economic and social inequality, immigration, health inequalities, and funding cuts to
community pharmacies.
Amid an audience that included stakeholders from the pharmacy sector, a notable query focused on each party's stance on the role of community pharmacies and
their commitment to funding these vital services.
After struggling with COVID, Hemant Petal is back to good health, and now he is on a mission to reduce "health inequalities".
Speaking at the SIGMA Conference 2023, he spoke about his new role as Clinical Lead, Health Inequalities and Population Health Management, SE Essex Alliance,
Essex ICB.
"So, my new role is outside pharmacy, nothing to do with pharmacy. But it is important, I feel that I share some of my insights about the work that I'm doing that
might benefit you," he said.
Elaborating on the role of integrated care boards (ICBs), he said that they are designed to enhance coordination and collaboration across different healthcare
providers and settings.
The representatives from hospitals, community services, retail and social care meet on a monthly basis to "look at where there are issues to be resolved, perhaps
what can be done to improve the healthcare services."
A recently published report on medicines optimisation highlights the urgent need for transformative changes across all pharmacies to unlock their full
potential in delivering integrated care.
The report by Public Policy Projects (PPP) is first of the four in the series that emphasises the significant benefits that medicines optimisation can bring to
integrated care systems (ICSs).
This includes reducing health inequalities and improving population health.
Pointing to the "untapped opportunity" that medicines optimisation presents for ICSs facing financial challenges, the report underscores the vital role of
pharmacies in enhancing patient outcomes.
The launch of the Pharmacy First services has already demonstrated the essential contribution of pharmacies to the health and care system.
With "medicines being the second highest cost to the NHS," the report recommends ways "to achieve better value for money while improving patient outcomes".
NHS England and NHS Improvement published on May 26 the findings of the Fuller 'stocktake' - setting out how primary care can work with partners across health
and care to best meet the needs of their local communities.
Dr Claire Fuller's report lays emphasis on the essential role of primary care and the potential of integrated neighbourhood teams in reducing the burden of ill health and tackling health inequities.
It commends community pharmacy for keeping "its doors open to the public throughout" the pandemic whilst being "among the most recognisable of a multitude of dedicated staff delivering care around the clock in every neighbourhood in the country". The report highlights "recruitment and retention challenges across the wider primary care workforce" including in community pharmacy.
Stressing the importance of community pharmacy teams in urgent care and prevention, including early diagnosis of cancers, the report points out that pharmacists could play "a more active role in signposting eligible people to screening and supporting early diagnosis, building on a number of successful pilots such as those from the Accelerate, Coordinate, Evaluate (ACE) programme".
Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been tasked to evaluate the impact, safety and effectiveness of the
Pharmacy First service, which was launched across England in January 2024.
They have been awarded £2.4million by the National Institute for Health and Care Research (NIHR) to generate evidence on the new service that allows
pharmacies to provide advice and treatment for seven common conditions without the need for a GP appointment.
After consultation, if necessary, a community pharmacist can supply some prescription-only medicines to treat earache, sore throat, sinusitis, impetigo,
shingles, infected insect bites or uncomplicated urinary tract infections in women.
The LSHTM researcher team will be working together with experts at the UK Health Security Agency (UKHSA) and the Universities of Oxford, Manchester and
Nottingham on the project.
Dr Rebecca Glover, assistant professor in Antimicrobial Resistance at LSHTM, who will lead the three-year project, said they will evaluate "Pharmacy First's
impact on GPs and the wider NHS, pharmacy services and patients."
The General Pharmaceutical Council (GPhC) has published a new strategy pledging to deliver equality, improve diversity and foster inclusion in all aspects of its work.
The strategy was updated after a public consultation held between April and July. It's key themes are:
To make regulatory decisions that are demonstrably fair, lawful, and free from discrimination and bias.
To use our standards to proactively help tackle discrimination and to make sure everyone can access person-centred care, fostering equality of health outcomes.To lead by example and demonstrate best practice within our organisation, holding ourselves to the same high standards we expect of others.
GPhC chair Nigel Clarke said having a strategy is vital as the pandemic has exposed "the scope and scale of inequities in society, in healthcare outcomes and in pharmacy."
"Inequality and exclusion are bad for people's health. Therefore, this strategy is fundamental to our core purpose as a regulator and our vision for safe and effective pharmacy care at the heart of healthier communities."
Leading pharmacy bodies and associations are looking forward to working with 'reappointed' Secretary of State for Health and Social Care, Steve Barclay, on
'future roles' and 'funding' for the community pharmacy.
The Royal Pharmaceutical Society (RPS) England Country Board Chair, Thorrun Govind, hopes that the ministers will now be able to focus on addressing the key
challenges facing the health service and the country.
"This means not just getting through the winter, but planning for and investing in the future."
She added: "It will be crucial to use the skills of all our health professions to support the NHS recovery, reduce health inequalities, manage the growing cost
of long-term conditions, and deliver best value from medicines.
Released on Monday morning, the election manifesto shared by the Liberal Democrats pledges to "strengthen patients' rights" by tackling public health
inequalities and providing early access to community services.
The Liberal Democrats Party's manifesto promises to address the issues at both the "front and back doors" of the National Health Service (NHS), which the party
claims has been plunged into crisis by the Conservatives.
Pledging to invest in public health and early access to community services, the party aims to "work towards a fairer and more sustainable long-term funding model
for pharmacies and build on the Pharmacy First approach to give patients more accessible routine services and ease the pressure on GPs."
The pledge also includes making prescriptions for people with chronic mental health conditions free on the NHS, as part of a wider commitment to review the entire
schedule of exemptions for prescription charges.
The ongoing pharmacist workforce crisis has posed a significant risk to patients' access to care, medicines and advice - particularly affecting the elderly and vulnerable living in areas with health inequalities.
Many from the sector have raised concerns about this issue with the Company Chemists' Association (CCA) recently acknowledging the shortage of pharmacists or pharmacy technicians in the country to meet the needs of patients and the NHS.
The trade body representing almost 50 per cent of the community pharmacy sector said that pharmacy teams are exhausted after working tirelessly during the pandemic,
adding that Covid, Brexit and NHS reforms have exacerbated the shortage.
Covid and winter-related sickness absences are adding to the strain and with Brexit it has become difficult to attract overseas pharmacists to the UK.